The Week Ahead: Hom...
Health Care: Drugs
Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)
$4.39 -0.04 | -0.90%
05/17/13 - 04:00 PM ET
Portfolios with ALXA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
Latest ALXA Headlines from TheStreet
- Top Insider Trades: AEGR VVTV CCO ALXA 01.23.13 | 08:01 am
- 5 Stocks With Big Insider Buying 01.02.13 | 11:01 am
- 13 Biotech Stock Predictions for 2013 01.02.13 | 06:01 am
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 6 Stocks On Winning Streaks Short Sellers Do Not Believe In 12.18.12 | 04:12 pm
- Stocks Socked Despite Upbeat China Numbers; Apple Falls 12.14.12 | 04:12 pm
- The Next Big Thing in Biotech: FDA Decisions
12.14.12 | 05:12 am - Alexza Pharma: Premium Selling Options Strategy 12.12.12 | 11:12 am
- Alexza Pharma: Run-Up Trade Into December's Approval Decisions 11.20.12 | 08:11 am
- 21 Most Volatile Biopharma Stocks Closing Out 2012 11.05.12 | 06:11 am
Press Releases for ALXA
- Alexza Announces Conference Call To Discuss Agreement With Teva To Market ADASUVE® In The U.S. - PR Newswire 05.08.13 | 08:05 am
- Teva And Alexza Announce Teva's License To Market ADASUVE® In The U.S. - PR Newswire 05.08.13 | 08:05 am
- Alexza Pharmaceuticals To Present At Antiepileptic Drug And Device Trials (AED) XII Conference Highlighting Advances In The Treatment Of Epilepsy - PR Newswire 05.06.13 | 09:05 am
- Update: Alexza To Report 2013 First Quarter Financial Results On Tuesday, May 14, 2013 - PR Newswire 05.01.13 | 07:05 pm
- Alexza To Report 2013 First Quarter Financial Results On Thursday, May 9, 2013 - PR Newswire 04.22.13 | 05:04 pm
- Peter W. Schineller Joins Alexza Pharmaceuticals As Senior Vice President And Chief Commercial Officer - PR Newswire 03.13.13 | 09:03 am
- Alexza To Report 2012 Year-End Financial Results On Tuesday, March 26, 2013 - PR Newswire 03.06.13 | 05:03 pm
- Alexza Pharmaceuticals' Corporate Presentation To Be Webcast At Three Upcoming Investor Conferences - PR Newswire 02.25.13 | 09:02 am
- Alexza Receives Marketing Authorization For ADASUVE® (Staccato® Loxapine) In The European Union - PR Newswire 02.21.13 | 09:02 am
- Alexza Pharmaceuticals Appoints J. Kevin Buchi To Its Board Of Directors - PR Newswire 01.03.13 | 09:01 am
Partner Headlines for ALXA
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- Good News for Alexza Pharma - Analyst Blog - NASDAQ 08.23.12 | 02:08 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.20.12 | 09:07 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.18.12 | 09:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.16.12 | 09:07 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 07.10.12 | 09:07 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.05.12 | 09:07 am
- Healthcare Insights: J&J Defends, Investors Rattle Repligen, Arena Anxiety Building - Wall St. Cheat Sheet 06.25.12 | 10:06 am
- Morning Market Movers - Benzinga 06.25.12 | 09:06 am
